CAPPA's researchers have a strong track record of engagement with industry. Early collaborations centred on activities in our Photonic Material & Devices Strand and as a consequence was primarily with the photonics sector. The seed funding provided by Enterprise Ireland through the Applied Research Enhancement Programme facilitated CAPPA's involvement with a wide variety of new sectors including Medical Devices & Technologies, Pharmaceuticals, Electronics and Food Technology while consolidating our interaction with the Photonics sector.
Benefits of Partnership
With photonics now positioned as a key enabling technology there is scope for CAPPA to bring value to a wide range of manufacturing and product design sectors outside of those identified above.
Access to resources and skills not available within your company or organisation. Flexibility to resource short, medium & long term projects. CAPPA can also open up the wider research community: CIT & Tyndall Company staff can be located at CAPPA to enhance collaboration. Opportunities for CAPPA researchers to locate at your facility. Experience of R&D projects within regulated environments: ISO, FDA, CE Mark, cGMP & cGAMP. Successful track record in securing both research and industrial funding. CAPPA technology has been commercially licensed.
- New Photonics Devices
- Med Tech & Pharmaceuticals
- Food & Beverages
- Manufacturing Technologies
Liam Lewis, CAPPA Gateway Manager
Find out more about the Technology Gateways Programme.